Your browser doesn't support javascript.
loading
The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study.
Almuradova, Elvina; Seyyar, Mustafa; Arak, Haci; Tamer, Fatih; Kefeli, Umut; Koca, Sinan; Sen, Erdem; Telli, Tugba Akin; Karatas, Fatih; Gokmen, Ivo; Turhal, Nazim Serdar; Sakalar, Teoman; Ayhan, Murat; Ekinci, Ferhat; Hafizoglu, Emre; Kahraman, Seda; Kesen, Oguzhan; Unal, Caglar; Alan, Ozkan; Celik, Serdar; Yekeduz, Emre; Omur, Ozgür; Gokmen, Erhan.
Afiliação
  • Almuradova E; Faculty of Medicine, Department of Medical Oncology, Ege University, Izmir, Turkey.
  • Seyyar M; Faculty of Medicine, Department of Medical Oncology, Kocaeli University, Kocaeli, Turkey.
  • Arak H; Department of Medical Oncology, Gaziantep University Sahinbey Research and Application Hospital, Gaziantep, Turkey.
  • Tamer F; Department of Nuclear Medicine, Nigde Omer Halisdemir University Training and Research Hospital, Nigde, Turkey.
  • Kefeli U; Faculty of Medicine, Department of Medical Oncology, Kocaeli University, Kocaeli, Turkey.
  • Koca S; Faculty of Medicine, Department of Medical Oncology, Medeniyet University, Istanbul, Turkey.
  • Sen E; Department of Medical Oncology, Canakkale Mehmet Akif Ersoy State Hospital, Canakkale, Turkey.
  • Telli TA; Department of Medical Oncology, Marmara Training and Research Hospital, Marmara, Turkey.
  • Karatas F; Department of Medical Oncology, Karabuk University, Karabuk, Turkey.
  • Gokmen I; Faculty of Medicine, Department of Medical Oncology, Trakya University, Trakya, Turkey.
  • Turhal NS; Department of Medical Oncology, Anatolian Health Center, Istanbul, Turkey.
  • Sakalar T; Department of Medical Oncology, Kahramanmaras Necip Fazil City Hospitals, Kahramanmaras, Turkey.
  • Ayhan M; Department of Medical Oncology, Kartal Dr Lütfi Kirdar City Hospital, Istanbul, Turkey.
  • Ekinci F; Department of Medical Oncology, Manisa Celal Bayar University, Manisa, Turkey.
  • Hafizoglu E; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
  • Kahraman S; Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey.
  • Kesen O; Department of Medical Oncology, Adana City Hospital, Adana, Turkey.
  • Unal C; Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey.
  • Alan O; Department of Medical Oncology, Tekirdag Ismail F. Cumaloglu City Hospital, Tekirdag, Turkey.
  • Celik S; Department of Urology, University of Health Sciences Turkey, Izmir Faculty Of Medicine, Izmir Bozyaka Education and Research Hospital, Izmir, Turkey.
  • Yekeduz E; Department of Medical Oncology, Adana City Hospital, Adana, Turkey.
  • Omur O; Faculty of Medicine, Department of Nuclear Medicine, Ege University, Izmir, Turkey.
  • Gokmen E; Faculty of Medicine, Department of Medical Oncology, Ege University, Izmir, Turkey.
Int J Cancer ; 154(4): 692-700, 2024 Feb 15.
Article em En | MEDLINE | ID: mdl-37818966
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Idioma: En Ano de publicação: 2024 Tipo de documento: Article